Video

How Medicare Part C and D 5-Star Quality Ratings Drive Changes in Pharmacy Practice

Troy Trygstad, PharmD, MBA, PhD, of Community Care of North Carolina, talks about how the Medicare Part C and D 5-star quality rating has driven changes in pharmacy practice.

Troy Trygstad, PharmD, MBA, PhD, of Community Care of North Carolina, talks about how the Medicare Part C and D 5-star quality rating has driven changes in pharmacy practice.

This video was recorded at APhA's 2015 annual meeting.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Immune evasion (pneumococci) Immunoscopic examination of the pneumococcal capsule: - Polysaccharide mantle (halo effect) obscures surface proteins - Complement C3b proteins (red) fail to clear
September 14th 2025

PCV21 Effective in Children, Adolescents at Increased Pneumococcal Disease Risk

Luke Halpern, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 14th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Infant with measles spot on back | Image Credit: © airdone - stock.adobe.com
September 14th 2025

Los Angeles Reports Fatal Case of a Rare Measles Complication Years After Infection

Alexandra Gerlach, Associate Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 14th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Atopic dermatitis. Red, itchy hands with blisters seen by a dermatologist
September 14th 2025

Amlitelimab Meaningfully Clears Skin in Moderate-to-Severe Atopic Dermatitis

Luke Halpern, Assistant Editor
Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com
September 14th 2025

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Brian Corvino Neal Masia, PhD Ali Pashazadeh George Van Antwerp, MBA Ned Milenkovich, PharmD, JD Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.